Conn. To Share In $105 Million Pharmaceutical Settlement

The Connecticut Law Tribune


The latest settlement involves a practice known as 'off-label marketing' in which drugmakers push medicines for uses beyond those approved by the regulator.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202658162337

Thank you!

This article's comments will be reviewed.